Christine Casey

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. ncbi Adverse events associated with smallpox vaccination in the United States, January-October 2003
    Christine G Casey
    Smallpox Vaccine Adverse Event Monitoring and Response Activity, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 294:2734-43. 2005
  2. ncbi Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions
    Christine Casey
    Immunization Safety Office, Office of the Chief Science Officer, Office of the Director, Atlanta, GA 30329, USA
    MMWR Recomm Rep 55:1-16. 2006
  3. ncbi Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January-October 2003
    Juliette Morgan
    Centers for Disease Control and Prevention and 2Department of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA
    Clin Infect Dis 46:S242-50. 2008
  4. ncbi Promise of new Japanese encephalitis vaccines
    Marc Fischer
    National Center for Zoonotic, Vector-Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Fort Collins, CO 80521, USA
    Lancet 370:1806-8. 2007
  5. ncbi Safety profile of smallpox vaccine: insights from the laboratory worker smallpox vaccination program
    James Baggs
    Centers for Disease Control and Prevention, National Immunization Program, Epidemiology and Surveillance Division, Immunization Safety Branch, 1600 Clifton Rd, Mailstop E61, Atlanta, GA 30333, USA
    Clin Infect Dis 40:1133-40. 2005
  6. ncbi Dermatological lesions near the smallpox vaccination site after scab detachment
    Andrew Kroger
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 46:S227-33. 2008
  7. ncbi Superinfection following smallpox vaccination (Vaccinia), United States: surveillance January 2003 through January 2004
    Claudia Vellozzi
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 39:1660-6. 2004
  8. ncbi Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) and corticosteroid therapy: eleven United States cases, 1996-2004
    Claudia Vellozzi
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Am J Trop Med Hyg 75:333-6. 2006
  9. ncbi Generalized vaccinia, progressive vaccinia, and eczema vaccinatum are rare following smallpox (vaccinia) vaccination: United States surveillance, 2003
    Claudia Vellozzi
    Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 41:689-97. 2005
  10. ncbi Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients
    Arnulfo A Muralles
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Vaccine 24:476-84. 2006

Collaborators

Detail Information

Publications13

  1. ncbi Adverse events associated with smallpox vaccination in the United States, January-October 2003
    Christine G Casey
    Smallpox Vaccine Adverse Event Monitoring and Response Activity, Epidemiology and Surveillance Division, National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 294:2734-43. 2005
    ....
  2. ncbi Surveillance guidelines for smallpox vaccine (vaccinia) adverse reactions
    Christine Casey
    Immunization Safety Office, Office of the Chief Science Officer, Office of the Director, Atlanta, GA 30329, USA
    MMWR Recomm Rep 55:1-16. 2006
    ..The smallpox vaccine surveillance case definitions presented in the report can be used in future vaccination programs to ensure uniform reporting guidelines and case classification...
  3. ncbi Myocarditis, pericarditis, and dilated cardiomyopathy after smallpox vaccination among civilians in the United States, January-October 2003
    Juliette Morgan
    Centers for Disease Control and Prevention and 2Department of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA
    Clin Infect Dis 46:S242-50. 2008
    ..We describe an association between smallpox vaccination, using the US vaccinia strain, and myo/pericarditis among civilians...
  4. ncbi Promise of new Japanese encephalitis vaccines
    Marc Fischer
    National Center for Zoonotic, Vector-Borne, and Enteric Diseases, Centers for Disease Control and Prevention, Fort Collins, CO 80521, USA
    Lancet 370:1806-8. 2007
  5. ncbi Safety profile of smallpox vaccine: insights from the laboratory worker smallpox vaccination program
    James Baggs
    Centers for Disease Control and Prevention, National Immunization Program, Epidemiology and Surveillance Division, Immunization Safety Branch, 1600 Clifton Rd, Mailstop E61, Atlanta, GA 30333, USA
    Clin Infect Dis 40:1133-40. 2005
    ..This report describes the frequency of such symptoms among 936 adult smallpox vaccinees with and without a history of prior smallpox vaccination...
  6. ncbi Dermatological lesions near the smallpox vaccination site after scab detachment
    Andrew Kroger
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Clin Infect Dis 46:S227-33. 2008
    ..Lesions were heterogeneous in morphology, clinical appearance, and histology. The evidence from our case series and follow-up suggests that these lesions are self-limited, without significant clinical sequelae...
  7. ncbi Superinfection following smallpox vaccination (Vaccinia), United States: surveillance January 2003 through January 2004
    Claudia Vellozzi
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 39:1660-6. 2004
    ..Superinfection is an adverse event following smallpox vaccination. The clinical presentation is similar to that of a large normal vaccine reaction or "robust take," and the frequency is unknown...
  8. ncbi Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) and corticosteroid therapy: eleven United States cases, 1996-2004
    Claudia Vellozzi
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Am J Trop Med Hyg 75:333-6. 2006
    ..The use of stress-dose steroids might be a factor that influenced the survival of these YEL-AVD patients and should be further evaluated in the management of both YEL-AVD and wild-type yellow fever septic shock...
  9. ncbi Generalized vaccinia, progressive vaccinia, and eczema vaccinatum are rare following smallpox (vaccinia) vaccination: United States surveillance, 2003
    Claudia Vellozzi
    Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 41:689-97. 2005
    ..GV may be difficult to distinguish from other rashes, and confirmatory testing is recommended. Careful prevaccination screening probably contributed to the low incidence of these adverse reactions following smallpox vaccination...
  10. ncbi Active telephone surveillance to evaluate adverse events among civilian smallpox vaccine recipients
    Arnulfo A Muralles
    National Immunization Program, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Vaccine 24:476-84. 2006
    ..5%), muscle pain (23.1%), chills (14.4%), joint pain 11.8%, and fever >100 degrees F (12.5%). The 12.5% reported missing work because of vaccine adverse events. Most adverse events were anticipated and of short duration...
  11. ncbi Recommendations for using smallpox vaccine in a pre-event vaccination program. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Healthcare Infection Control Practices Advisory Committee (HICPAC)
    Melinda Wharton
    Epidemiology and Surveillance Division, National Center for Infectious Diseases, USA
    MMWR Recomm Rep 52:1-16. 2003
    ..Revised recommendations will be developed as needed...
  12. ncbi Smallpox vaccination and adverse reactions. Guidance for clinicians
    Joanne Cono
    Bioterrorism Preparedness and Response Program, National Center for Infectious Diseases, USA
    MMWR Recomm Rep 52:1-28. 2003
    ..asp. Physicians at military medical facilities can request VIG or cidofovir by calling the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) at 301-619-2257 or 888-USA-RIID...
  13. ncbi The ocular complications of smallpox and smallpox immunization
    Janine A Smith
    Arch Ophthalmol 122:1407; author reply 1407-8. 2004